These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5245252)

  • 21. [Effects of radiological therapy combined with anticancer drugs].
    Takahashi N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1967 Jul; 27(4):406-20. PubMed ID: 5237724
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of a bovine thymus extract (TP-1) on implantation and development of Yoshida ascitic sarcoma in the rat. I].
    Venuti A; Fimiani V; Gioffre' MA; Micali B
    Chir Patol Sper; 1982 Aug; 29(4):161-6. PubMed ID: 7172845
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of a bovine thymus extract (TP-1) on implantation and development of Yoshida ascitic sarcoma in the rat. II].
    Venuti A; Gioffre' MA; Micali B; Caputo G
    Chir Patol Sper; 1982 Aug; 29(4):167-71. PubMed ID: 7172846
    [No Abstract]   [Full Text] [Related]  

  • 24. Anticancer potential of N,N-diethylaminoethyl ethers of flavanone oximes: a comparison with mitoxantrone action on rat Yoshida sarcoma cells in vivo.
    Metodiewa D; Kochman A; Koceva-Chyła A
    Anticancer Res; 1999; 19(2A):1249-54. PubMed ID: 10368684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies on the natural sensitization by normal intestinal flora, especially by E. coli. 12. Antitumor activity of endotoxin of E. coli normally present in the intestines].
    Tamura H; Matsumura T
    Nihon Saikingaku Zasshi; 1967 Jan; 22(1):31-6. PubMed ID: 4862738
    [No Abstract]   [Full Text] [Related]  

  • 26. Assessment of drugs.
    Schneiderman MA; Myers MH
    Science; 1965 Sep; 149(3690):1398. PubMed ID: 5826539
    [No Abstract]   [Full Text] [Related]  

  • 27. New radiosensitizing regimens, drugs, prodrugs, and candidates.
    Vallerga AK; Zarling DA; Kinsella TJ
    Clin Adv Hematol Oncol; 2004 Dec; 2(12):793-805. PubMed ID: 16166960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cytotoxic effect of plasmin on Yoshida sarcoma cells.
    Hilgard P; Hiemeyer V
    Rev Fr Etud Clin Biol; 1969 Nov; 14(9):902-4. PubMed ID: 4243799
    [No Abstract]   [Full Text] [Related]  

  • 29. [Reoxygenation in Yoshida sarcoma during different fractionated radiotherapy].
    Strnad V; Kamprad F; Jahns J; Kirschner M; Meyer M; Madaj-Sterba P; Riepl M; Böhme R; Sauer R
    Strahlenther Onkol; 1996 Nov; 172(11):619-25. PubMed ID: 8975393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytembena administered in combination with cyclophosphamide in Yoshida ascitic sarcoma.
    Veselá H; Jelínek V; Pujman V; Zlatkovská Z
    Neoplasma; 1971; 18(5):459-64. PubMed ID: 5119519
    [No Abstract]   [Full Text] [Related]  

  • 31. [The cytotoxic effect of plasmin on yoshida sarcoma cells].
    Hiemeyer V; Hilgard P; Kottmann R
    Z Krebsforsch; 1969; 72(1):36-42. PubMed ID: 4183690
    [No Abstract]   [Full Text] [Related]  

  • 32. Influence of the chemical structure on the biological endency of cytostatic compounds related to dibromomannitol. I. Structure-activity correlations.
    Institóris L; Horváth IP; Csányi E
    Arzneimittelforschung; 1967 Feb; 17(2):145-9. PubMed ID: 5631481
    [No Abstract]   [Full Text] [Related]  

  • 33. COX-2 inhibitors as radiosensitizing agents for cancer therapy.
    Davis TW; Hunter N; Trifan OC; Milas L; Masferrer JL
    Am J Clin Oncol; 2003 Aug; 26(4):S58-61. PubMed ID: 12902857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxygen cytotoxicity in tumour cells.
    Bozzi A; Mavelli I; Mondovi B; Strom R; Rotilio G
    Bull Eur Physiopathol Respir; 1981; 17 Suppl():267-71. PubMed ID: 7248576
    [No Abstract]   [Full Text] [Related]  

  • 35. Cross-resistance studies on 1,6-dibromo-dideoxy-D-mannitol(DBM)-resistant Yoshida S.C. sarcoma.
    Csányi E; Halász M
    Br J Cancer; 1967 Jun; 21(2):353-7. PubMed ID: 6028086
    [No Abstract]   [Full Text] [Related]  

  • 36. [Studies with Proresid (SP-I) in various innoculation tumors].
    Osswald H; Schmähl D
    Med Klin; 1966 Apr; 61(17):681-4. PubMed ID: 5995181
    [No Abstract]   [Full Text] [Related]  

  • 37. [Strain of Yoshida sarcoma with induced pafencil resistance].
    Khomchenovskiĭ EI; Burova GF
    Biull Eksp Biol Med; 1985 Apr; 99(4):479-81. PubMed ID: 3986376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Studies on the radiation sensitizing effect of 6-anaurazilribosid depending on the irradiation time in the Ehrlich tumor].
    Magdon E; Konopatzky R; Sterescu M
    Strahlentherapie; 1968 Aug; 136(2):237-40. PubMed ID: 5695894
    [No Abstract]   [Full Text] [Related]  

  • 39. [Studies on the effect of 6-azauracilriboside in the irradiation of experimental animal tumors].
    Magdon ; Konopatzky R
    Arch Geschwulstforsch; 1967; 29(3):259-65. PubMed ID: 5595236
    [No Abstract]   [Full Text] [Related]  

  • 40. Cytochemical characterization of Yoshida sarcoma cells resistant to dibromodulcitol.
    Gáti E; Pokorny E; Somfai-Relle S; Szentirmay Z
    Int J Tissue React; 1984; 6(1):43-51. PubMed ID: 6715118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.